| Tracking the evolution of non–small-cell lung cancer M Jamal-Hanjani, GA Wilson, N McGranahan, NJ Birkbak, TBK Watkins, ... New England Journal of Medicine 376 (22), 2109-2121, 2017 | 2170 | 2017 |
| Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution C Abbosh, NJ Birkbak, GA Wilson, M Jamal-Hanjani, T Constantin, ... Nature 545 (7655), 446-451, 2017 | 1675 | 2017 |
| Allele-specific HLA loss and immune escape in lung cancer evolution N McGranahan, R Rosenthal, CT Hiley, AJ Rowan, TBK Watkins, ... Cell 171 (6), 1259-1271. e11, 2017 | 1154 | 2017 |
| Progress and prospects of early detection in lung cancer S Blandin Knight, PA Crosbie, H Balata, J Chudziak, T Hussell, C Dive Open biology 7 (9), 170070, 2017 | 846 | 2017 |
| Fc effector function contributes to the activity of human anti-CTLA-4 antibodies FA Vargas, AJS Furness, K Litchfield, K Joshi, R Rosenthal, E Ghorani, ... Cancer cell 33 (4), 649-663. e4, 2018 | 537 | 2018 |
| The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets SL Wood, M Pernemalm, PA Crosbie, AD Whetton Cancer treatment reviews 40 (4), 558-566, 2014 | 434 | 2014 |
| Fc-optimized anti-CD25 depletes tumor-infiltrating regulatory T cells and synergizes with PD-1 blockade to eradicate established tumors FA Vargas, AJS Furness, I Solomon, K Joshi, L Mekkaoui, MH Lesko, ... Immunity 46 (4), 577-586, 2017 | 413 | 2017 |
| Tracking genomic cancer evolution for precision medicine: the lung TRACERx study M Jamal-Hanjani, A Hackshaw, Y Ngai, J Shaw, C Dive, S Quezada, ... PLoS biology 12 (7), e1001906, 2014 | 301 | 2014 |
| Implementing lung cancer screening: baseline results from a community-based ‘Lung Health Check’pilot in deprived areas of Manchester PA Crosbie, H Balata, M Evison, M Atack, V Bayliss-Brideaux, D Colligan, ... Thorax 74 (4), 405-409, 2019 | 213 | 2019 |
| Molecular histology of lung cancer: from targets to treatments SL Wood, M Pernemalm, PA Crosbie, AD Whetton Cancer treatment reviews 41 (4), 361-375, 2015 | 200 | 2015 |
| Long-term macrolide therapy in chronic inflammatory airway diseases PAJ Crosbie, MA Woodhead European Respiratory Journal 33 (1), 171-181, 2009 | 186 | 2009 |
| Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse F Chemi, DG Rothwell, N McGranahan, S Gulati, C Abbosh, SP Pearce, ... Nature medicine 25 (10), 1534-1539, 2019 | 170 | 2019 |
| Circulating tumor cells detected in the tumor-draining pulmonary vein are associated with disease recurrence after surgical resection of NSCLC PAJ Crosbie, R Shah, P Krysiak, C Zhou, K Morris, J Tugwood, R Booton, ... Journal of Thoracic Oncology 11 (10), 1793-1797, 2016 | 96 | 2016 |
| Second round results from the Manchester ‘Lung Health Check’community-based targeted lung cancer screening pilot PA Crosbie, H Balata, M Evison, M Atack, V Bayliss-Brideaux, D Colligan, ... Thorax 74 (7), 700-704, 2019 | 72 | 2019 |
| Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual … PAJ Crosbie, R Gabe, I Simmonds, M Kennedy, S Rogerson, N Ahmed, ... BMJ open 10 (9), e037075, 2020 | 64 | 2020 |
| Nodal staging in lung cancer: a risk stratification model for lymph nodes classified as negative by EBUS-TBNA M Evison, J Morris, J Martin, R Shah, PV Barber, R Booton, PAJ Crosbie Journal of Thoracic Oncology 10 (1), 126-133, 2015 | 57 | 2015 |
| A study of patients with isolated mediastinal and hilar lymphadenopathy undergoing EBUS-TBNA M Evison, PAJ Crosbie, J Morris, J Martin, PV Barber, R Booton BMJ Open Respiratory Research 1 (1), e000040, 2014 | 57 | 2014 |
| The cost-effectiveness of the Manchester ‘lung health checks’, a community-based lung cancer low-dose CT screening pilot S Hinde, T Crilly, H Balata, R Bartlett, J Crilly, P Barber, A Threlfall, ... Lung Cancer 126, 119-124, 2018 | 52 | 2018 |
| KRAS induces lung tumorigenesis through microRNAs modulation L Shi, J Middleton, YJ Jeon, P Magee, D Veneziano, A Laganà, HS Leong, ... Cell death & disease 9 (2), 219, 2018 | 52 | 2018 |
| EBUS-TBNA in elderly patients with lung cancer: safety and performance outcomes M Evison, PAJ Crosbie, J Martin, P Bishop, H Doran, L Joseph, ... Journal of Thoracic Oncology 9 (3), 370-376, 2014 | 52 | 2014 |
